JADENU®

Indications

Jadenu is indicated for the treatment of chronic iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) in patients with beta thalassaemia major aged 6 years and older.

Jadenu is also indicated for the treatment of chronic iron overload due to blood transfusions when deferoxamine therapy is contraindicated or inadequate in the following patient groups:

• in patients with other anaemias,
• in patients aged 2 to 5 years,
• in patients with beta thalassaemia major with iron overload due to infrequent blood
• transfusions (<7 ml/kg/month of packed red blood cells).

Jadenu is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.